Speaker

Thimmaiah Chendrimada

Founder, Able Sciences

Thimmaiah Chendrimada, Founder at Able Sciences, is speaking at 4th Cell Therapy for Autoimmune Disease Summit 2026 (Philadelphia, United States of America, 1–3 Dec 2026) in the session “Morning Workshop: Moving Beyond CD19 to Identify the Next-Generation of Clinically Viable Targets”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

4th Cell Therapy for Autoimmune Disease Summit 2026
1–3 Dec 2026Philadelphia, United States of America
- WorkshopMorning Workshop: Moving Beyond CD19 to Identify the Next-Generation of Clinically Viable TargetsWith Daniel Shelly
- SpeakerEvaluating RNA-Based In Vivo CAR-T Platforms Against Established Delivery Technologies

More speakers at 4th Cell Therapy for Autoimmune Disease Summit 2026

Fred Aslan
President & Chief Executive Officer, Artiva Biotherapeutics, Inc
Rena Baek
Executive Director, Preclinical Development, Moderna
Michael Mingueneau
Vice President, Immunology, Sail Biomedicines
Edward Zhang
Co-Founder & Chief Executive Officer, Overland Therapeutics
Mark Bach
Chief Medical Officer, GentiBio
Nathalie Belmonte
Chief Science & Technical Officer, Quell Therapeutics

See all 21 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Thimmaiah Chendrimada, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].